SCHEMBL785831

SCHEMBL785831

CCCCCCCCCCCCCC(=O)NCCCN(CC)CC

nearest known ligand 0.73

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.73
FAAH O00519 5/20 0.64
NAAA Q02083 1/20 0.61
CASP2 P42575 1/20 0.59
GAA P10253 1/20 0.56
PAOX Q6QHF9 1/20 0.54
EPHX2 P34913 3/20 0.53
SELP P16109 1/20 0.53
CNR1 P21554 1/20 0.51
ALDH1A1 P00352 1/20 0.51
HPGD P15428 1/20 0.51
TRPV1 Q8NER1 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL76256 1.00 DNM1 (0.73) DNM1FAAHNAAACASP2GAA
SCHEMBL76220 1.00 DNM1 (0.73) DNM1FAAHNAAACASP2GAA
SCHEMBL74739 1.00 DNM1 (0.73) DNM1FAAHNAAACASP2GAA
SCHEMBL117354 1.00 DNM1 (0.73) DNM1FAAHNAAACASP2GAA
SCHEMBL75692 1.00 DNM1 (0.73) DNM1FAAHNAAACASP2GAA
SCHEMBL8396456 1.00 DNM1 (0.73) DNM1FAAHNAAACASP2GAA
SCHEMBL8394943 1.00 DNM1 (0.73) DNM1FAAHNAAACASP2GAA
Hydrochloric Acid SCHEMBL9542376 0.98 DNM1 (0.71) DNM1FAAHNAAACASP2GAA
Hydrochloric Acid SCHEMBL17394704 0.98 DNM1 (0.71) DNM1FAAHNAAACASP2GAA
SCHEMBL8398351 0.98 DNM1 (0.70) DNM1FAAHNAAACASP2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120321576-A1 SUNSCREEN COMPOSITION SHISEIDO COMPANY, LTD. (JP) 2012-12-20 US claimed
US-20080214456-A1 Lkktet and/or Lkktnt Peptide Compositions and Methods REGENERX BIOPHARMACEUTICALS, INC. (US) 2008-09-04 US claimed
EP-1896050-A2 LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS AND METHODS Regenerx Biopharmaceuticals, Inc. (US) 2008-03-12 EP claimed
WO-2006138709-A2 LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS AND METHODS REGENERX BIOPHARMACEUTICALS, INC. (US) 2006-12-28 WO claimed
US-20260098007-A1 Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light SOLIOME INC (US) 2026-04-09 US disclosed
EP-4587007-A2 COMPOUNDS AND THEIR USE IN FILTERING ULTRAVIOLET AND/OR HIGH-ENERGY VISIBLE LIGHT Soliome, Inc. (US) 2025-07-23 EP disclosed
EP-4587635-A2 FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS Evolved by Nature, Inc. (US) 2025-07-23 EP disclosed
US-20250230203-A1 FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS EVOLVED BY NATURE, INC. 2025-07-17 US disclosed
WO-2024059862-A9 FIBROIN PEPTIDES AND PROTEIN FRAGMENTS COMPOSITIONS EVOLVED BY NATURE, INC. (US) 2025-04-24 WO disclosed
US-20240408174-A1 SILK STIMULATED COLLAGEN AND CLAUDIN-1 EXPRESSION, AND SILK STIMULATED ANTI-INFLAMMATORY EFFECTS EVOLVED BY NATURE, INC. 2024-12-12 US disclosed
US-20240307285-A1 SUNSCREENS DERIVED FROM KYNURENINES AND OTHER UV-ABSORBING OXIDIZED AMINO ACIDS BOUND TO PEPTIDES OR POLYMERS THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2024-09-19 US disclosed
EP-4419071-A1 SILK STIMULATED COLLAGEN AND CLAUDIN-1 EXPRESSION, AND SILK STIMULATED ANTI-INFLAMMATORY EFFECTS Evolved by Nature, Inc. (US) 2024-08-28 EP disclosed
EP-0764663-A2 Method of improving the electrical conductivity of a molding artcile of resin, method of coating a molding article of resin, and coating composition NIPPON PAINT CO., LTD. (JP) 1997-03-26 EP disclosed
US-5571472-A KNEADING AND MOLDING A RESIN WITH AMINOALKYLAMIDES DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 1996-11-05 US disclosed
EP-0675505-A1 A method of improving the electrical conductivity of shaped resin articles and an electrostatic coating process DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) 1995-10-04 EP disclosed
EP-0013713-B1 PHOSPHORUS CONTAINING SURFACE ACTIVE AGENTS AND THEIR PREPARATION Mona Industries (US) 1984-04-11 EP disclosed
US-4380637-A ZWITTERIONIC SURFACTANTS JOHNSON & JOHNSON/MONA INDUSTRIES, INC. (US) 1983-04-19 US disclosed
US-4283542-A BY REACTING PHOSPHATE ESTER WITH AN AMINE TO PRODUCE AN AMPHOTERIC SURFACTANT MONA INDUSTRIES (US) 1981-08-11 US disclosed
EP-0013713-A1 Phosphorus containing surface active agents and their preparation Mona Industries (US) 1980-08-06 EP disclosed
US-4215064-A SURFACTANTS JOHNSON & JOHNSON (US) 1980-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098007-A1 Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light UGT8, UGT1A3, FUT5 DNM1 4729/4885FAAH 2934/4885NAAA 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.